{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":3,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":3,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"83d4008d5c07","filters":{"venue":"Section 5: Patient safety and quality assurance"}},"results":[{"id":"W4293229876","doi":"10.1136/ejhpharm-2022-eahp.275","title":"5PSQ-041 Safety and efficacy of high doses of irinotecan in patients with metastatic colorectal cancer treated with FOLFIRI scheme based on UGT1A1 genotype: a systematic review","year":2022,"lang":"en","type":"review","venue":"Section 5: Patient safety and quality assurance","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Fundación Vital Fundazioa","keywords":"Irinotecan; Jadad scale; Medicine; FOLFIRI; Internal medicine; Colorectal cancer; Observational study; Oncology; Randomized controlled trial; Meta-analysis; Pharmacology; Cancer; Cochrane Library","authors":[{"name":"Marta Miarons","is_ca":false},{"name":"P Riera-Armengol","is_ca":false},{"name":"S García-Gil","is_ca":false},{"name":"F Gutiérrez- Nicolás","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02306352273737329,"gpt":0.2923180049184177,"spread":0.2692544821810444,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002935121,0.001049967,0.006569341,0.005532811,0.0003780669,0.001566467,0.001179864,0.001348417,0.005620036],"category_scores_gemma":[0.01532856,0.0006144986,0.008288337,0.006004361,0.0005196056,0.001238236,0.000943412,0.0007559828,0.0002909903],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002220069,"about_ca_system_score_gemma":0.00572881,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007579393,"about_ca_topic_score_gemma":0.01988528,"domain_scores_codex":[0.9975421,0.0006825197,0.001001574,0.000271543,0.0003982938,0.0001039583],"domain_scores_gemma":[0.9891422,0.007088167,0.002450261,0.0001474221,0.001029472,0.0001424135],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0004221413,0.00001447181,0.00165267,0.9561186,0.01841165,0.00007071388,0.0001029721,0.0001087592,0.0002363777,0.0001307871,0.001397087,0.02133375],"study_design_scores_gemma":[0.0007443122,0.0004700595,0.01446172,0.7253926,0.238738,0.0005606425,0.000250654,0.0001567363,0.0002537089,0.0003884459,0.01852764,0.00005548765],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003368237,0.9936376,0.0001290268,0.0002986741,0.0001106543,0.0002998137,0.001696832,0.00001343168,0.0004457631],"genre_scores_gemma":[0.04255443,0.9538367,0.0004816405,0.001047625,0.0001170443,0.0006186484,0.001089415,0.000008898821,0.0002455452],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007579393,"threshold_uncertainty_score":0.01880085,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4360614809","doi":"10.1136/ejhpharm-2023-eahp.324","title":"5PSQ-134 Unit dose in a cyberattack scenario","year":2023,"lang":"en","type":"article","venue":"Section 5: Patient safety and quality assurance","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medical prescription; Pharmacy; Computer science; Workstation; Medical emergency; Service (business); Medicine; Operating system; Nursing","authors":[{"name":"Alberto M. Soares","is_ca":false},{"name":"AM Simões","is_ca":false},{"name":"Paulo Victor Viana dos Santos","is_ca":false},{"name":"PAULA RENATA DO NASCIMENTO ALMEIDA","is_ca":false},{"name":"M Rodrigues","is_ca":false},{"name":"Andressa Griebler Gusmão","is_ca":false},{"name":"A Alcobia","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08673984244305188,"gpt":0.3551708130173303,"spread":0.2684309705742784,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008291344,0.0003496516,0.000410951,0.0005961467,0.001708169,0.001702533,0.0008507294,0.002319811,0.01036845],"category_scores_gemma":[0.003177716,0.0003376552,0.0005484377,0.0007221173,0.001213627,0.001351737,0.002068021,0.001771196,0.001805539],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002670849,"about_ca_system_score_gemma":0.001238408,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005159858,"about_ca_topic_score_gemma":0.005203964,"domain_scores_codex":[0.9985585,0.0004750603,0.000141382,0.0001777222,0.0002844419,0.0003628556],"domain_scores_gemma":[0.9980324,0.0006353023,0.0004173595,0.0001271933,0.0001557719,0.0006320511],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.002825195,0.002190288,0.2003708,0.0008023222,0.0001088055,0.6357582,0.006975727,0.01404692,0.005841788,0.01722284,0.04433759,0.06951953],"study_design_scores_gemma":[0.0003918725,0.00441922,0.09430131,0.0008725806,0.000177849,0.6596436,0.01809727,0.03987415,0.01427087,0.01498158,0.1526375,0.0003321208],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9321749,0.001809438,0.007188914,0.01973808,0.0004789299,0.0002835095,0.001044256,0.0005140459,0.03676802],"genre_scores_gemma":[0.9905214,0.0005705538,0.002286431,0.00196951,0.0001795599,0.00004687001,0.0002741523,0.00007542563,0.004076073],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01036845,"threshold_uncertainty_score":0.03468585,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2945764188","doi":"10.1136/ejhpharm-2019-eahpconf.444","title":"5PSQ-011 Venous thromboembolic events and total hip or knee arthroplasty: incidence and associated factors","year":2019,"lang":"en","type":"article","venue":"Section 5: Patient safety and quality assurance","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Rivaroxaban; Dabigatran; Venous thromboembolism; Arthroplasty; Total knee arthroplasty; Medical prescription; Internal medicine; Surgery; Warfarin; Thrombosis; Atrial fibrillation","authors":[{"name":"A Etangsale","is_ca":false},{"name":"B Kadri","is_ca":false},{"name":"C Balouzet","is_ca":false},{"name":"E Snobbert","is_ca":false},{"name":"Sophie Pargade","is_ca":false},{"name":"Sandra Camps","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02156177797199561,"gpt":0.2733416329539053,"spread":0.2517798549819097,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000422465,0.0002250633,0.0001673482,0.0009458282,0.0002466518,0.0004463626,0.0002339874,0.0003752185,0.006658248],"category_scores_gemma":[0.00152868,0.00009081382,0.0004406146,0.002105447,0.0002240057,0.0002904409,0.0003236419,0.0003980417,0.0005829703],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000361108,"about_ca_system_score_gemma":0.0005094939,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007337354,"about_ca_topic_score_gemma":0.004245591,"domain_scores_codex":[0.9996607,0.00007422076,0.00004719923,0.00005139333,0.00008912932,0.00007727607],"domain_scores_gemma":[0.9986015,0.0001593782,0.0008080872,0.00002153769,0.0001676461,0.0002419393],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00003742093,0.00001634329,0.9982553,0.00002189478,0.00002172656,0.00007230526,0.00001598694,0.00002877147,0.00004239943,0.00002884801,0.0003478837,0.001111165],"study_design_scores_gemma":[0.000005691396,0.00004654053,0.9985271,0.00002208446,0.00001803782,0.0004675168,0.00009721697,0.0001262376,0.00002174902,0.00004578164,0.0006196563,0.000002317439],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9880567,0.00259886,0.000224664,0.0005690947,0.0000519151,0.00003010535,0.005327149,0.00001066598,0.003130832],"genre_scores_gemma":[0.9967244,0.000519925,0.0001217984,0.00009629419,0.00004350995,0.00001466017,0.002069865,0.000001934959,0.000407667],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007337354,"threshold_uncertainty_score":0.02227408,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}